An office visit may help when joint soreness limits your day

Soreness that changes daily life deserves an exam

A visit may help when several days of sensible home care haven't calmed the soreness. It's also time to call when walking, sleep, or getting dressed keeps becoming harder.

The doctor may ask about your comfortable walking distance or how high you can reach. Name the daily task you can't finish, not only the place that hurts.

When wear is mild, the doctor may discuss a joint shot, medicine, gentle exercise, or a fitted brace. An X-ray can't choose the right one by itself.

Bone-on-bone wear may call for a surgery talk

A bone-on-bone joint may bend poorly, give way, or hurt during ordinary household chores. No joint shot has shown that it can rebuild tissue with that much wear.

You don't have to make a surgery decision during the first visit, even when the X-ray looks severe and your days have become much harder. Ask about timing, recovery, likely cost, and the help you'll need at home.

Exercise may still help with strength and safer movement before any final decision. Ask your doctor whether it still makes sense in your case.

Urgent warning signs need faster care than a booked visit

A fever with strong heat and swelling around one joint may mean an infection. You'll need prompt medical care, especially after any recent procedure on that joint.

After a fall, a bent-looking joint or trouble standing may mean a broken bone. Don't drive yourself when you feel faint, weak, or unsafe behind the wheel.

New weakness, spreading numbness, or loss of bowel or bladder control also needs urgent help. A normal clinic appointment can't safely handle those warning signs.

A useful visit leaves you knowing what comes next

Ask what the doctor noticed during the exam, and ask if an X-ray would add useful information. It's fair to ask what still isn't known about the soreness.

Before agreeing to care, ask about likely relief, possible risks, full price, and return visits. Don't let an unfamiliar treatment name hurry your decision.

You may leave with home care, another exam, or a choice that avoids surgery. Take enough time to think the choices over.

Sources

1. A randomized, double-blind, placebo-controlled trial in a Japanese population tested leukocyte-POOR PRP specifically in mild-to-moderate knee OA WITH joint effusion or bone marrow lesions - i.e. a selected inflammatory phenotype rather than all comers. Recorded here because phenotype selection, not the product, is the most plausible explanation for why PRP trials disagree with one another.

   Yoshioka T, et al. — The Effectiveness of Leukocyte-Poor Platelet-Rich Plasma Injections for Symptomatic Mild to Moderate Osteoarthritis of the Knee With Joint Effusion or Bone Marrow Lesions in a Japanese Population: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.. The American journal of sports medicine, 2024. DOI: 10.1177/03635465241263073.

2. A randomized trial in the New England Journal of Medicine compared physical therapy against intra-articular glucocorticoid injection for knee osteoarthritis and found physical therapy produced better WOMAC outcomes at one year. When a clinic offers an injection, the comparator that matters is not 'nothing' - it is a course of supervised exercise.

   Deyle GD, et al. — Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee.. The New England journal of medicine, 2020. DOI: 10.1056/NEJMoa1905877.

3. The Cochrane review of exercise for knee osteoarthritis found high-quality evidence that land-based therapeutic exercise provides short-term benefit in pain and physical function, sustained for at least 2-6 months after the programme ends, with mild transient soreness the only reported adverse effect across 45 trials. It is the best-evidenced treatment for this condition and it costs nothing per injection.

   Fransen M, et al. — Exercise for osteoarthritis of the knee.. The Cochrane database of systematic reviews, 2015. DOI: 10.1002/14651858.CD004376.pub3.

4. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

5. The AAOS clinical practice guideline summary on SURGICAL management of knee osteoarthritis - the other end of the ladder, and the honest comparator for anyone told a biologic injection will let them avoid an operation.

   Srivastava AK, et al. — American Academy of Orthopaedic Surgeons Clinical Practice Guideline Summary of Surgical Management of Osteoarthritis of the Knee.. The Journal of the American Academy of Orthopaedic Surgeons, 2023. DOI: 10.5435/JAAOS-D-23-00338.

6. A CDC-led national public health investigation identified culture-confirmed bacterial infections in 20 patients (median age 63) across 8 US states who received umbilical cord blood-derived products marketed as stem cell treatment for pain, osteoarthritis, rheumatoid arthritis and injury. ALL BUT ONE REQUIRED HOSPITALISATION. Of unopened, undistributed product vials sampled, 65% (22 of 34) were contaminated with at least one of 16 bacterial species, mostly enteric; whole-genome sequencing linked an Arizona patient isolate to product administered in Florida.

   Hartnett KP, et al. — Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood-Derived Products Marketed as Stem Cell Therapies.. JAMA network open, 2021. DOI: 10.1001/jamanetworkopen.2021.28615.